Bio Pharma Dive
JANUARY 9, 2025
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with menopause as well as a common breast cancer therapy.
Rethinking Clinical Trials
JANUARY 9, 2025
The NIH Pragmatic Trials Collaboratory will hold a virtual workshop on February 5 and 6, 2025, on Digging Into Dilemmas of Pragmatic Clinical Trials. A keynote presentation will address the state of healthcare delivery in the United States and the constraints on healthcare systems that are important for researchers to understand. Day 1 of the workshop will develop participants understanding of the landscape for pragmatic research, including stressors on the healthcare system and barriers and opp
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 9, 2025
Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
Pharmaceutical Technology
JANUARY 9, 2025
Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
JANUARY 9, 2025
The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as potent in early testing as the company expected.
Pharmaceutical Technology
JANUARY 9, 2025
Aspect Biosystems has secured $115m in a Series B financing round to advance the development of bioprinted tissue therapeutics.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JANUARY 9, 2025
The EC has approved the extension of Stallergenes Greers Palforzia for the treatment of peanut allergy in toddlers.
Bio Pharma Dive
JANUARY 9, 2025
Nearly 30% of the funding poured into healthcare startups last year, including for biotechs, went to companies leveraging artificial intelligence, according to Silicon Valley Bank.
Pharmaceutical Technology
JANUARY 9, 2025
Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.
AuroBlog - Aurous Healthcare Clinical Trials blog
JANUARY 9, 2025
CMV-infected human placental cell. (Nephron/CC BY-SA 3.0/Wikimedia Commons) Researchers have discovered a link between a chronic gut infection caused by a common virus and the development of Alzheimer’s disease in some people. Most people encounter cytomegalovirus (CMV) during childhood, and after the initial infection the virus remains in the body for life, usually dormant.
Pharmaceutical Technology
JANUARY 9, 2025
Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and cardiometabolic disease.
Pharma Times
JANUARY 9, 2025
Groundbreaking approval provides new hope for patients in England and Wales
Pharmaceutical Technology
JANUARY 9, 2025
Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and Mitsubishi Tanabe with deals announced on the same day.
pharmaphorum
JANUARY 9, 2025
Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
JANUARY 9, 2025
The FDAs new draft guidance for developers of AI-enabled medical devices marks a critical milestone in addressing the complexities of transparency, bias and safety throughout the lifecycle of these advanced technologies. Tailored for manufacturers and stakeholders, it outlines strategies to ensure devices meet high standards of efficacy and inclusivity.
pharmaphorum
JANUARY 9, 2025
A new obesity start-up Verdiva Bio has just decloaked with a whopping $411m to advance a once-weekly oral GLP-1 agonist.
Pharma Times
JANUARY 9, 2025
CR-discovered NXP800 shows promise in clinical trials
pharmaphorum
JANUARY 9, 2025
Pharma groups have called for EU adoption of electronic product information (ePI) to take place within four years in a new position paper.
Outsourcing Pharma
JANUARY 9, 2025
India's Anthem Biosciences is planning to raise $397m in an initial public offering (IPO).
pharmaphorum
JANUARY 9, 2025
GSK is reportedly in negotiations about a $1bn deal to acquire IDRx and its targeted therapy for a form of rare gastrointestinal tumour.
ACRP blog
JANUARY 9, 2025
Many current trends in clinical research will likely continue regardless of the upcoming changes in the White House. The need to incorporate technology into our clinical trials processes, alongside a continued emphasis on the power of artificial intelligence ( AI) , will remain a priority for both the U.S. Food and Drug Administration (FDA) and the rest of government in 2025.
pharmaphorum
JANUARY 9, 2025
Grifols has filed for US approval of its new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), aiming for a first-in-class launch.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
JANUARY 9, 2025
Newly launched company, Verdiva Bio, is aiming to advance oral and injectable drugs for obesity, with it backed by an oversubscribed Series A financing round of $411m.
Pharma Marketing Network
JANUARY 9, 2025
Table of Contents Sr# Headings 1 Introduction: Navigating the Pharma Marketing Network 2 Building a Strong Pharma Marketing Network 3 Strategies for Digital Success in Pharma Marketing 4 Leveraging Data and Partnerships for Impact Introduction: Navigating the Pharma Marketing Network The Pharma Marketing Network is more than just a collection of professionalsits a dynamic ecosystem where strategy, creativity, and innovation converge.
Pharmaceutical Commerce
JANUARY 9, 2025
The program intends to address supply chain challenges surrounding product safety, traceability, and counterfeiting.
Pharma Marketing Network
JANUARY 9, 2025
Table of Contents Sr# Headings 1 Introduction: Why Staying Updated on Pharma News Matters 2 Emerging Trends in Pharma Marketing 3 The Role of Technology in Modern Pharma Strategies 4 Adapting to Regulatory Changes and Compliance Introduction: Why Staying Updated on Pharma News Matters In the fast-paced pharmaceutical industry, information is power. For marketing teams, staying ahead of the curve with the latest Pharma News can mean the difference between a campaign that thrives and one that fall
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioPharma Reporter
JANUARY 9, 2025
MaaT Pharma is focused on developing microbiome-related therapies and its lead candidate is MaaT013, a treatment for acute graft-versus-host disease (aGvHD) with gastrointestinal involvement.
Pharma Marketing Network
JANUARY 9, 2025
Table of Contents Sr# Headings 1 Introduction: The Evolution of Pharmaceutical Marketing 2 Patient-Centric Marketing: Putting Patients First 3 Digital Transformation in Pharma Marketing 4 Building Trust Through Data and Compliance Introduction: The Evolution of Pharmaceutical Marketing In todays fast-paced world, pharmaceutical marketing is no longer about just promoting productsits about connecting, educating, and empowering.
pharmaphorum
JANUARY 9, 2025
In pharmaphorums inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
Pharmaceutical Commerce
JANUARY 9, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
267 
Let's personalize your content